EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

José Manuel Sánchez-Maldonado, Angelica Macauda, Antonio José Cabrera-Serrano, Hauke Thomsen, Murat Güler, Rob Ter Horst, Bethany van Guelpen iD, Pavel Vodicka, Stefano Landi iD, Subhayan Chattopadhyay, Pelin Ünal, Lucía Ruiz-Durán und 43 weitere

International Journal of Cancer · 15.07.2026 · 159 (2) · 410-422

DOI: 10.1002/ijc.70427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 11.03.2026. Verfasst von José Manuel Sánchez-Maldonado und 54 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada…. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Monoclonal Gammopathy of Undetermined Significance, Cyclin-Dependent Kinase Inhibitor p16, Protein Serine-Threonine Kinases. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union's Horizon 2020 research and innovation programme, Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER, Dietmar Hopp Foundation, and the German Ministry of Education and Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal gammopathy of undetermined significance (MGUS) is a necessary precursor condition to multiple myeloma (MM). Given the role of autophagy in modulating MM risk, we investigated whether genetic variation in autophagy‐related genes influences susceptibility to MGUS. We analyzed the association of 34,042 common autophagy‐related single nucleotide polymorphisms (SNPs) with MGUS across six independent cohorts, five from Europe and one from North America, comprising 2317 MGUS cases and 282,358 controls. We also assessed their impact on immune parameters, including absolute counts of 91 blood‐derived immune cell subsets and 103 circulating immunological proteins. Meta‐analysis revealed a genome‐wide significant association between the ULK4 rs6599175C allele and increased MGUS risk ( p = 3.35 × 10 −8 ). Carriers of this allele showed reduced counts of memory B cell subsets (IgM+CD38+CD27+ and IgD+IgM+CD27+; p = .0038 and p = .0056, respectively) and natural effector B cells (CD24+CD38+IgD+IgM+ cells; p = .0060). Although these associations were not statistically significant after multiple testing correction, they suggest a role of ULK4 in early B‐cell differentiation. Additionally, the CDKN2A rs2811710 variant showed a suggestive association with MGUS risk ( p = 2.17 × 10 −4 ), affecting transcription factor binding involved in B‐cell proliferation and differentiation, although it lacked association with immune markers. In conclusion, we confirm a genome‐wide significant association of the ULK4 locus and MGUS risk, supporting its role in early B‐cell differentiation, and identify CDKN2A as a candidate susceptibility locus warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideMonoclonal Gammopathy of Undetermined SignificanceCyclin-Dependent Kinase Inhibitor p16Protein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsHumansGenetic Predisposition to DiseaseFemaleMaleGenome-Wide Association StudyCase-Control StudiesMiddle AgedAgedAutophagy

Stichwörter der Autor:innen

MGUSautophagyblood‐derived cell populationsgenetic variantssusceptibility

Substanzen

Cyclin-Dependent Kinase Inhibitor p16CDKN2A protein, humanProtein Serine-Threonine KinasesIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, Spain.
  • Instituto de Investigación Biosanataria IBs.Granada, Granada, Spain.
  • Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • MSB Medical School Berlin, Berlin, Germany.
  • Medical Faculty, Heidelberg University, Heidelberg, Germany.
  • Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.

ORCID-Profile: Bethany van Guelpen, Stefano Landi, Delphine Casabonne, Victor Moreno, Francesca Tavano, Michelle A T Hildebrandt, Börge Schmidt, Rui Manuel Vieira Reis, Daniele Campa, Asta Försti, Federico Canzian, Juan Sainz

Förderung

  • European Union's Horizon 2020 research and innovation programme
  • Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER
  • Dietmar Hopp Foundation, and the German Ministry of Education and Science
  • CRIS Foundation against cancer, the Cancer Network of Excellence
  • SALVAGE
  • National Cancer Institute of the National Institutes of Health
  • Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk
  • Italian Ministry of Health through the Ricerca Corrente program 2025-2027

Zitieren

APA

Sánchez-Maldonado, J. M., Macauda, A., Cabrera-Serrano, A. J., Thomsen, H., Güler, M., Horst, R. T., van Guelpen, B., Vodicka, P., Landi, S., Chattopadhyay, S., Ünal, P., Ruiz-Durán, L., Casabonne, D., Goldschmidt, H., Serin, I., Carretero-Fernández, M., Cabezudo, E., Reyes-Zurita, F., Norman, A. D., …, & Sainz, J. (2026). ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance. International Journal of Cancer, 159(2), 410-422. https://doi.org/10.1002/ijc.70427

Vancouver

Sánchez-Maldonado JM, Macauda A, Cabrera-Serrano AJ, Thomsen H, Güler M, Horst RT, et al. ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance. International Journal of Cancer. 2026;159(2):410-422. doi:10.1002/ijc.70427

BibTeX
@article{SnchezMaldonado2026,
  author = {Sánchez-Maldonado, José Manuel and Macauda, Angelica and Cabrera-Serrano, Antonio José and Thomsen, Hauke and Güler, Murat and Horst, Rob Ter and van Guelpen, Bethany and Vodicka, Pavel and Landi, Stefano and Chattopadhyay, Subhayan and Ünal, Pelin and Ruiz-Durán, Lucía and Casabonne, Delphine and Goldschmidt, Hartmut and Serin, Istemi and Carretero-Fernández, María and Cabezudo, Elena and Reyes-Zurita, Fernando and Norman, Aaron D and García-Sanz, Ramón and Capurso, Gabriele and Hoffmann, Per and Pettersson-Kymmer, Ulrika and Jiménez-Romera, Francisco and Rajkumar, S Vincent and Weinhold, Niels and Vodickova, Ludmila and Langer, Christian and Stein, Angelika and Karismaz, Abdulkadir and Moreno, Victor and Nöthen, Markus M and Jöckel, Karl-Heinz and Tavano, Francesca and Martínez-López, Joaquín and Kumar, Shaji K and Gutiérrez-Bautista, Juan Francisco and Basso, Daniela and Späth, Florentin and Benavente, Yolanda and Hildebrandt, Michelle A T and Schmidt, Börge and Sevcikova, Tereza and Reis, Rui Manuel Vieira and Li, Yang and López-Nevot, Miguel Ángel and Netea, Mihai G and Campa, Daniele and Clay-Gilmour, Alyssa and Slager, Susan L and Hemminki, Kari and Vachon, Celine M and Försti, Asta and Canzian, Federico and Sainz, Juan},
  title = {ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {2},
  pages = {410--422},
  doi = {10.1002/ijc.70427}
}
Kostenlos starten →